Verana Health: $150m Series E funding
Digital health company Verana Health has announced a $150m USD Series E funding round, led by Johnson and Johnson Holdings – JJDC, and Novo Growth. The company plans to use the investment to advance its various solutions and enhance its value proposition to customers participating in its real-world data network.
“The healthcare industry needs new ways of creating high-quality data sets from disorganized information dispersed throughout a myriad of electronic health record systems that often lack interoperability and standardization,” said David Parke, the company’s executive chairman and CEO of its first medical society partner, the American Academy of Ophthalmology. “Verana Health is solving this critical need by delivering and analyzing proprietary, curated data sets (Qdata), from both structured and unstructured data that maintain truth to original clinical context; the company is well-positioned to help healthcare providers advance quality care standards, and life sciences companies accelerate clinical research and bring products to market that benefit both patients and physicians.”